Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis
Toxicology Research · 28.06.2023 · 12 (3) · 392-399
DOI: 10.1093/toxres/tfad024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicology Research, online erschienen am 20.04.2023. Verfasst von Wei Peng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Changsha Social Work College, Changsha 410018, Hunan Province, China. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Scientific Research Program of Traditional Chinese Medicine of Hunan Province, Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Celastrol is a biologically active compound with potent anti-tumor properties. However, the mechanism of action of celastrol in gastric cancer (GC) has not been fully elucidated.
Methods
To explore the specific mechanism of the effect of celastrol on GC cells. GC cells were transfected with forkhead box A1 (FOXA1) or claudin 4 (CLDN4), or short hairpin RNA targeting FOXA1. The expressions of FOXA1 and CLDN4 in GC cells were determined by quantitative reverse transcription PCR and Western blot. GC cell proliferation, migration, and invasion were measured by MTT assay and Transwell assay, respectively. The interaction between CLDN4 and FOXA1 was examined by luciferase reporter assay. Resluts CLDN4 and FOXA1 were upregulated in GC cells. Celastrol prevented the proliferation, migration, and invasion of GC cells by downregulating FOXA1 expression. Overexpression of FOXA1 or CLDN4 accelerated GC progression. CLDN4 overexpression also induced the activation of the expressions of phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pathway. FOXA1 enhanced the transcription of CLDN4.
Conclusion
Celastrol regulated GC progression via targeting the FOXA1/CLDN4 axis to impede the PI3K/AKT pathway. Our study proposed a new mechanism of how celastrol inhibited tumorigenesis in GC, which provided evidence for the potential use of celastrol for anti-GC treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Changsha Social Work College, Changsha 410018, Hunan Province, China.
- Department of Internal Medicine, The First Affiliated Hospital of Changsha Medical College, Changsha 410219, Hunan Province, China.
Förderung
- Scientific Research Program of Traditional Chinese Medicine of Hunan Province
- Natural Science Foundation of China
Zitieren
APA
Peng, W., Chen, L., & Liu, J. (2023). Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis. Toxicology Research, 12(3), 392-399. https://doi.org/10.1093/toxres/tfad024
Vancouver
Peng W, Chen L, Liu J. Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis. Toxicology Research. 2023;12(3):392-399. doi:10.1093/toxres/tfad024
BibTeX
@article{Peng2023,
author = {Peng, Wei and Chen, Lin and Liu, Jie},
title = {Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis},
journal = {Toxicology Research},
year = {2023},
volume = {12},
number = {3},
pages = {392--399},
doi = {10.1093/toxres/tfad024}
}
EUVIMED